Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease
about
Pre-admission antibiotics for suspected cases of meningococcal diseasePre-admission antibiotics for suspected cases of meningococcal diseaseMeasurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescenceTowards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnectPreparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugatesMinimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugatesComplement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9Infectious diseases associated with complement deficiencies.Construction of acetate auxotrophs of Neisseria meningitidis to study host-meningococcal endotoxin interactions.Picogram doses of lipopolysaccharide exacerbate antibody-mediated thrombocytopenia and reduce the therapeutic efficacy of intravenous immunoglobulin in mice.Complement activation and pulmonary dysfunction in experimental Escherichia coli septicaemia.A normal platelet count at admission in acute meningococcal disease does not exclude a fulminant course.Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugatesLipopolysaccharides up-regulate Kir6.1/SUR2B channel expression and enhance vascular KATP channel activity via NF-kappaB-dependent signalingInnate immune responses of synthetic lipid A derivatives of Neisseria meningitidisCellular and molecular biology of Neisseria meningitidis colonization and invasive diseaseUpdate on meningococcal disease with emphasis on pathogenesis and clinical managementSystemic endotoxin levels in chronic indolent periodontal infections.NafA negatively controls Neisseria meningitidis piliation.The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal disease.Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria.Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine releaseEndotoxemia: methods of detection and clinical correlatesLipooligosaccharide structure contributes to multiple steps in the virulence of Neisseria meningitidis.New therapies and vaccines for meningococcal disease.Low levels of vitronectin and clusterin in acute meningococcal disease are closely associated with formation of the terminal-complement complex and the vitronectin-thrombin-antithrombin complex.Neisseria meningitidis: biology, microbiology, and epidemiology.Parenteral penicillin for children with meningococcal disease before hospital admission: case-control studyEndotoxemia and the host systemic response during experimental gingivitis.Meningococcal disease: treatment and prevention.Activation of toll-like receptor 2 (TLR2) and TLR4/MD2 by Neisseria is independent of capsule and lipooligosaccharide (LOS) sialylation but varies widely among LOS from different strains.Intracellular Acid-extruding regulators and the effect of lipopolysaccharide in cultured human renal artery smooth muscle cells.Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosa.Pathophysiology of meningococcal meningitis and septicaemiaEndothelial cell adhesion molecules in meningococcal diseaseHigh levels of interleukin 10 in serum are associated with fatality in meningococcal disease.Role of endotoxemia in cardiovascular dysfunction and lethality: virulent and nonvirulent Escherichia coli challenges in a canine model of septic shock.Antiendotoxin activity of cationic peptide antimicrobial agents.Endotoxemia in pediatric critical illness--a pilot study.Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy
P2860
Q24200590-3DC5980D-1441-4F32-BADD-A5CE97621904Q24242705-E800D24F-016D-49A9-9D47-533D69639585Q24801390-14D2D8A7-AB28-4623-9079-415DBD079B11Q26996658-06C85E6E-9F51-40CB-9682-E4D9FE7E6DD2Q28333277-70E65BC5-F5B3-42D9-B469-62EF91D2E3F9Q28333417-C727750C-D267-4AAE-B9F7-7C457FDBDA35Q28362359-BC3A177F-C3FB-4F6D-BEDB-B8A1AA5D18B2Q30450183-3043AD0C-9319-4FF5-967A-AD57CA71AB4DQ31577999-91E6D05A-BE20-489A-94B4-3AB3873FAF43Q33376821-4C36353A-84A0-43C0-A594-AE3BEA30D6B5Q33389130-57C177B2-D7EC-44B4-8ACA-2D064D197FD9Q33502103-48DAAC84-68BB-4B0A-ADB2-74E2152CDF49Q33595722-F5116E51-F64B-4C7B-AA7D-1AF74008F765Q33661652-97826FD0-BDFB-41D6-8579-E54D39B77317Q33696667-769A9633-03D5-4A29-860D-DCFADFCAC65CQ33696949-CF04D48F-B648-41C7-99D4-8AC8850AB780Q33812435-B3ACD215-0B2C-410D-B3E2-6B482321C5CBQ33917860-EE4F8C4E-720E-42DB-9BBD-DE08CB8EC212Q33958083-7CEEA893-7617-49BB-8A88-6F3322B9BBFCQ33963083-A35F545B-0624-4630-BEBA-11FBFCF7B09BQ34008246-969DF96A-9F0F-4E22-8641-C8315E37A5CCQ34255810-86A3A1B5-F373-4B5B-BA92-A36B628F2100Q34300796-72BDD4A0-5496-4DA5-8BF4-735E37D2F98CQ34334420-6A19F816-16C2-43F0-AC19-96C4C18E183CQ34481640-B14962D4-C5E9-407E-B831-182024861C57Q34544169-9B812969-C29D-4065-A4C5-B685F4856BA6Q34632986-7DBC5A40-2824-4C48-A2B2-27E8642EB983Q34654727-F41DBA9C-27D8-442C-B48C-44E11B266085Q34785885-BBB439EE-4F38-4327-BC3D-9224F3CC5149Q35055030-D50DA106-CA8A-4540-B757-E90CC9D4FC0CQ35105676-5050159B-4EA5-4EE0-BC49-6911506D9B13Q35108910-ED356682-3C36-4BBD-8D05-238F9BDB0CC9Q35122113-68578C6B-3825-46EA-B271-5EF58ED6919DQ35159278-C775C63D-35D6-4132-A00D-A467ECE379D2Q35261780-90A29CFE-48E3-4BD1-9057-F70015AA303FQ35414992-297FB930-74EC-482B-AA72-ADE78F33E3DFQ35465958-C3A18CAB-29EB-47FF-A387-5E9E83EC9D44Q35530704-ADE0EB77-5BB2-4F52-B4EB-C51C3283BF30Q35558313-9BA615D8-1E4F-49FE-85A9-5077A53467CFQ35599013-674C0881-EF37-435B-B6DE-0A252097A0BB
P2860
Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease
description
im Februar 1989 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 February 1989
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 1989
@uk
name
Plasma Endotoxin as a Predicto ...... Systemic Meningococcal Disease
@fr
Plasma endotoxin as a predicto ...... systemic meningococcal disease
@en
Plasma endotoxin as a predicto ...... systemic meningococcal disease
@nl
type
label
Plasma Endotoxin as a Predicto ...... Systemic Meningococcal Disease
@fr
Plasma endotoxin as a predicto ...... systemic meningococcal disease
@en
Plasma endotoxin as a predicto ...... systemic meningococcal disease
@nl
prefLabel
Plasma Endotoxin as a Predicto ...... Systemic Meningococcal Disease
@fr
Plasma endotoxin as a predicto ...... systemic meningococcal disease
@en
Plasma endotoxin as a predicto ...... systemic meningococcal disease
@nl
P2093
P356
P1476
Plasma endotoxin as a predicto ...... systemic meningococcal disease
@en
P2093
A Skulberg
E Sørensen
S Halvorsen
P304
P356
10.1093/INFDIS/159.2.195
P407
P577
1989-02-01T00:00:00Z